vocal fold nodules
Conditions
Interventions
1:Midazolam0.03mg/Kg+propofol3ug/ml +remifentanil4-6ug/ml+Cis-atracurium0.1mg/kg
2:Midazolam0.03mg/Kg+propofol3ug/ml +remifentanil4-6ug/ml
Sponsors
Department of Anesthesiology, the First Hospital of Jilin University, Changchun, China
Eligibility
Sex/Gender
Male
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were: age > 18 years and < 65 years, body mass index (BMI) of 18.5–25 kg/m2, class I or II physical status according to the American Society of Anesthesiologists (ASA) and Mallampati class (a measure predicting the ease of intubation) I or II, and scheduling for elective suspension laryngoscopic excision under IWMR.
Exclusion criteria
Exclusion criteria: The exclusion criteria were: a medical history of myopathy; a known history of allergy to propofol and/or remifentanil or drug abuse; and/or a previous history of upper respiratory tract infection within 3 weeks of enrollment, gastrointestinal reflux, intracranial pathology, suspected difficult airway, or serious cardiopulmonary or hepatorenal insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| post-anesthesia recovery times; | — |
Countries
China
Contacts
Public ContactHaichun Ma
Outcome results
None listed